| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5892819 | Bone | 2007 | 5 Pages |
Abstract
Reducing the initial zoledronic acid dose in children decreased the incidence of hypocalcaemia and thus improved safety. Dosing on the basis of body mass index or body surface area instead of body weight may further reduce the incidence of hypocalcaemia.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Craig F. Munns, Mansoor H. Rajab, Janet Hong, Julie Briody, Wolfgang Högler, Mary McQuade, David G. Little, Christopher T. Cowell,